
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses
Brock A. Humphries, Zhishan Wang, Chengfeng Yang
Cells (2020) Vol. 9, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 59
Brock A. Humphries, Zhishan Wang, Chengfeng Yang
Cells (2020) Vol. 9, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 75
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 75
Role of RhoA/ROCK signaling in Alzheimer’s disease
Ruo-Lan Cai, Yangyang Wang, Zhenting Huang, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113481-113481
Closed Access | Times Cited: 65
Ruo-Lan Cai, Yangyang Wang, Zhenting Huang, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113481-113481
Closed Access | Times Cited: 65
The C. elegans anchor cell: A model to elucidate mechanisms underlying invasion through basement membrane
Isabel W. Kenny-Ganzert, David R. Sherwood
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 23-34
Closed Access | Times Cited: 16
Isabel W. Kenny-Ganzert, David R. Sherwood
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 23-34
Closed Access | Times Cited: 16
Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach
Ioana-Ecaterina Pralea, Radu-Cristian Moldovan, Adrian Bogdan Țigu, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1087-1087
Open Access | Times Cited: 5
Ioana-Ecaterina Pralea, Radu-Cristian Moldovan, Adrian Bogdan Țigu, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1087-1087
Open Access | Times Cited: 5
Pan-cancer drivers of metastasis
Ryan Lusby, Engin Demirdizen, Mohammed Inayatullah, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Ryan Lusby, Engin Demirdizen, Mohammed Inayatullah, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Alternative splicing of transposable elements in human breast cancer
Alex Nesta, Diogo F. T. Veiga, Jacques Banchereau, et al.
Mobile DNA (2025) Vol. 16, Iss. 1
Open Access
Alex Nesta, Diogo F. T. Veiga, Jacques Banchereau, et al.
Mobile DNA (2025) Vol. 16, Iss. 1
Open Access
Bioinformatics-Driven Investigations of Signature Biomarkers for Triple-Negative Breast Cancer
Shristi Handa, Sanjeev Puri, Mary Chatterjee, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Shristi Handa, Sanjeev Puri, Mary Chatterjee, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
CSN-CRL Complexes: New Regulators of Adipogenesis
Dawadschargal Dubiel, Michael Naumann, Wolfgang Dubiel
Biomolecules (2025) Vol. 15, Iss. 3, pp. 372-372
Open Access
Dawadschargal Dubiel, Michael Naumann, Wolfgang Dubiel
Biomolecules (2025) Vol. 15, Iss. 3, pp. 372-372
Open Access
Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target
Abdollah Jafarzadeh, Mohammad Hossein Paknahad, Maryam Nemati, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112600-112600
Open Access | Times Cited: 32
Abdollah Jafarzadeh, Mohammad Hossein Paknahad, Maryam Nemati, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112600-112600
Open Access | Times Cited: 32
OBSCN restoration via OBSCN-AS1 long-noncoding RNA CRISPR-targeting suppresses metastasis in triple-negative breast cancer
Talia Guardia, Yuqi Zhang, Keyata N. Thompson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 12
Talia Guardia, Yuqi Zhang, Keyata N. Thompson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 12
Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment
Nasim Ebrahimi, Kamyar Kharazmi, Masoud Ghanaatian, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 11-24
Open Access | Times Cited: 17
Nasim Ebrahimi, Kamyar Kharazmi, Masoud Ghanaatian, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 11-24
Open Access | Times Cited: 17
Increased expression of ECT2 predicts the poor prognosis of breast cancer patients
Ming Yi, Di Zhang, Bin Song, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Ming Yi, Di Zhang, Bin Song, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights
Eleonora Sarantelli, Apostolis Mourkakis, Lefteris C. Zacharia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11253-11253
Open Access | Times Cited: 9
Eleonora Sarantelli, Apostolis Mourkakis, Lefteris C. Zacharia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11253-11253
Open Access | Times Cited: 9
LZTR1: A promising adaptor of the CUL3 family (Review)
Hui Zhang, Xinyi Cao, Jian Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Hui Zhang, Xinyi Cao, Jian Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Rho GTPase signalling networks in cancer cell transendothelial migration
Wessel S Rodenburg, Jaap D. van Buul
Vascular Biology (2021) Vol. 3, Iss. 1, pp. R77-R95
Open Access | Times Cited: 21
Wessel S Rodenburg, Jaap D. van Buul
Vascular Biology (2021) Vol. 3, Iss. 1, pp. R77-R95
Open Access | Times Cited: 21
Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer
Ailed Cruz‐Collazo, Jean F. Ruiz-Calderón, Hector Picon, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 12, pp. 2420-2432
Open Access | Times Cited: 20
Ailed Cruz‐Collazo, Jean F. Ruiz-Calderón, Hector Picon, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 12, pp. 2420-2432
Open Access | Times Cited: 20
PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
Duaa Alkaabi, Kholoud Arafat, Shahrazad Sulaiman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6420-6420
Open Access | Times Cited: 8
Duaa Alkaabi, Kholoud Arafat, Shahrazad Sulaiman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6420-6420
Open Access | Times Cited: 8
Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy
Mohamed A. Soltan, Muhammad Alaa Eldeen, Bayan H. Sajer, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 613-613
Open Access | Times Cited: 8
Mohamed A. Soltan, Muhammad Alaa Eldeen, Bayan H. Sajer, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 613-613
Open Access | Times Cited: 8
The mevalonate pathway in breast cancer biology
Andy Göbel, Romy M. Riffel, Lorenz C. Hofbauer, et al.
Cancer Letters (2022) Vol. 542, pp. 215761-215761
Closed Access | Times Cited: 13
Andy Göbel, Romy M. Riffel, Lorenz C. Hofbauer, et al.
Cancer Letters (2022) Vol. 542, pp. 215761-215761
Closed Access | Times Cited: 13
Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era
Anca-Narcisa Neagu, Pathea Bruno, Kaya R. Johnson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4113-4113
Open Access | Times Cited: 2
Anca-Narcisa Neagu, Pathea Bruno, Kaya R. Johnson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4113-4113
Open Access | Times Cited: 2
Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder
Vincent Sauzeau, J. Beignet, Christian Bailly
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1357-1357
Open Access | Times Cited: 11
Vincent Sauzeau, J. Beignet, Christian Bailly
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1357-1357
Open Access | Times Cited: 11
HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1
Xiaoqi Han, Siyuan Jiang, Yinmin Gu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Xiaoqi Han, Siyuan Jiang, Yinmin Gu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
Zhe Jiang, YoungJun Ju, Amjad Ali, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Zhe Jiang, YoungJun Ju, Amjad Ali, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis
Nabila Kazmi, Tim Robinson, Jie Zheng, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Nabila Kazmi, Tim Robinson, Jie Zheng, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
The ‘Yin and Yang’ of Cancer Cell Growth and Mechanosensing
Malak Amer, Lidan Shi, Haguy Wolfenson
Cancers (2021) Vol. 13, Iss. 19, pp. 4754-4754
Open Access | Times Cited: 14
Malak Amer, Lidan Shi, Haguy Wolfenson
Cancers (2021) Vol. 13, Iss. 19, pp. 4754-4754
Open Access | Times Cited: 14